Neuropathologic correlates of late-onset major depression. (Q53366660)

13 May 2018

title

Neuropathologic correlates of late-onset major depression. (English)

1 reference

13 May 2018

author

David A. Lewis

6

1 reference

13 May 2018

Steven T. DeKosky

object named as

Steven T DeKosky

8

0 references

Charles F. Reynolds III

9

object named as

Charles F Reynolds

1 reference

13 May 2018

4

Benoit H Mulsant

1 reference

13 May 2018

Meryl A Butters

3

object named as

Meryl A Butters

1 reference

13 May 2018

author name string

Robert A Sweet

1

1 reference

13 May 2018

Ronald L Hamilton

2

1 reference

13 May 2018

Bruce G Pollock

5

1 reference

13 May 2018

Oscar L Lopez

7

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 December 2004

1 reference

13 May 2018

published in

Neuropsychopharmacology

1 reference

13 May 2018

volume

29

1 reference

13 May 2018

issue

12

1 reference

13 May 2018

page(s)

2242-2250

1 reference

13 May 2018

The natural history of Alzheimer's disease. Description of study cohort and accuracy of diagnosis

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

Staging of Alzheimer's disease-related neurofibrillary changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

Paroxetine versus nortriptyline in the continuation and maintenance treatment of depression in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

Changes in cognitive functioning following treatment of late-life depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

APOE is associated with age-of-onset, but not cognitive functioning, in late-life depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

Indirect Self-Destructive Behavior Among Elderly Patients in Nursing Homes: A Research Agenda

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

Depression as a risk factor for Alzheimer disease: the MIRAGE Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

Contribution of Lewy body inclusions to dementia in patients with and without Alzheimer disease neuropathological conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

Psychiatric history and related exposures as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

Clinical risk factors for Alzheimer's disease: a population-based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

Long-term follow-up of depressive pseudodementia of the aged.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

Research evaluation and diagnosis of possible Alzheimer's disease over the last two decades: II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades: I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

Severity of cognitive impairment and the clinical diagnosis of AD with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

The establishment of a brain bank for the study of late-life depression: a feasibility study of factors facilitating consent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

DSM-III disorders in a large sample of psychiatric patients: frequency and specificity of diagnoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

Cognitive impairment in depression is not associated with neuropathologic evidence of increased vascular or Alzheimer-type pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

Early association of reactive astrocytes with senile plaques in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

Bedside assessment of executive cognitive impairment: the executive interview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

Brain infarction and the clinical expression of Alzheimer disease. The Nun Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

Expression of differential immune factors in temporal cortex and cerebellum: the role of alpha-1-antichymotrypsin, apolipoprotein E, and reactive glia in the progression of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

A neuropathological study of vascular factors in late-life depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

Interaction between genetic and environmental risk factors for Alzheimer's disease: a reanalysis of case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

Psychotic symptoms in Alzheimer's disease are not associated with more severe neuropathologic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

The Nature and Determinants of Neuropsychological Functioning in Late-LifeDepression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

The course of geriatric depression with "reversible dementia": a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

inferred from DOI database lookup

7 January 2021

based on heuristic

Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

inferred from DOI database lookup

7 January 2021

based on heuristic

A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300554

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.NPP.1300554

1 reference

13 May 2018

Dimensions Publication ID

1022975945

0 references

1 reference

13 May 2018